TY - JOUR AU - White, N. J. PY - 2007 DA - 2007// TI - Cardiotoxicity of antimalarial drugs JO - Lancet Infect Dis VL - 7 UR - https://doi.org/10.1016/S1473-3099(07)70187-1 DO - 10.1016/S1473-3099(07)70187-1 ID - White2007 ER - TY - JOUR AU - Nosten, F. AU - ter Kuile, F. O. AU - Luxemburger, C. AU - Woodrow, C. AU - Kyle, D. E. AU - Chongsuphajaisiddhi, T. PY - 1993 DA - 1993// TI - Cardiac effects of antimalarial treatment with halofantrine JO - Lancet VL - 341 UR - https://doi.org/10.1016/0140-6736(93)92412-M DO - 10.1016/0140-6736(93)92412-M ID - Nosten1993 ER - TY - STD TI - World Health Organization. Guidelines for the treatment of malaria. Third edition. 2015. http://apps.who.int/iris/bitstream/handle/10665/162441/9789241549127_eng.pdf;jsessionid=FF86896C56304582909FE8E5C71BB30A?sequence=1. Accessed 18 Oct 2018. UR - http://apps.who.int/iris/bitstream/handle/10665/162441/9789241549127_eng.pdf;jsessionid=FF86896C56304582909FE8E5C71BB30A?sequence=1 ID - ref3 ER - TY - STD TI - European Medicines Agency. Eurartesim - summary of product characteristics. 2011. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001199/WC500118113.pdf. Accessed 18 Oct 2018. UR - http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001199/WC500118113.pdf ID - ref4 ER - TY - JOUR AU - Gutman, J. AU - Kovacs, S. AU - Dorsey, G. AU - Stergachis, A. AU - Ter Kuile, F. O. PY - 2016 DA - 2016// TI - Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis JO - Lancet Infect Dis VL - 17 ID - Gutman2016 ER - TY - JOUR AU - Yap, Y. AU - Camm, J. PY - 2003 DA - 2003// TI - Drug induced QT prolongation and Torsades de Pointes JO - Heart. VL - 89 UR - https://doi.org/10.1136/heart.89.11.1363 DO - 10.1136/heart.89.11.1363 ID - Yap2003 ER - TY - JOUR AU - Bouchaud, O. AU - Imbert, P. AU - Touze, J. E. AU - Dodoo, A. N. O. AU - Danis, M. AU - Legros, F. PY - 2009 DA - 2009// TI - Fatal cardiotoxicity related to halofantrine: a review based on a worldwide safety data base JO - Malar J VL - 8 UR - https://doi.org/10.1186/1475-2875-8-289 DO - 10.1186/1475-2875-8-289 ID - Bouchaud2009 ER - TY - JOUR AU - Llanos-Cuentas, A. AU - Lacerda, M. V. AU - Rueangweerayut, R. AU - Krudsood, S. AU - Gupta, S. K. AU - Kochar, S. K. PY - 2014 DA - 2014// TI - Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study JO - Lancet VL - 383 UR - https://doi.org/10.1016/S0140-6736(13)62568-4 DO - 10.1016/S0140-6736(13)62568-4 ID - Llanos-Cuentas2014 ER - TY - JOUR AU - Poravuth, Y. AU - Socheat, D. AU - Rueangweerayut, R. AU - Uthaisin, C. AU - Pyae Phyo, A. AU - Valecha, N. PY - 2011 DA - 2011// TI - Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0014501 DO - 10.1371/journal.pone.0014501 ID - Poravuth2011 ER - TY - JOUR AU - Na-Bangchang, K. AU - Limpaibul, L. AU - Thanavibul, A. AU - Tan-Ariya, P. AU - Karbwang, J. PY - 1994 DA - 1994// TI - The pharmacokinetics of chloroquine in healthy Thai subjects and patients with Plasmodium vivax malaria JO - Br J Clin Pharmacol VL - 38 UR - https://doi.org/10.1111/j.1365-2125.1994.tb04354.x DO - 10.1111/j.1365-2125.1994.tb04354.x ID - Na-Bangchang1994 ER - TY - JOUR AU - Khan, S. J. AU - Munib, S. PY - 2005 DA - 2005// TI - Efficacy of halofantrine hydrochloride in vivax malaria JO - J Postgrad Med Inst VL - 19 ID - Khan2005 ER - TY - JOUR AU - Win, K. AU - Than, M. AU - Thwe, Y. PY - 1992 DA - 1992// TI - Comparison of combinations of parenteral artemisinin derivatives plus oral mefloquine with intravenous quinine plus oral tetracycline for treating cerebral malaria JO - Bull World Health Organ VL - 70 ID - Win1992 ER - TY - JOUR AU - Harinasuta, T. AU - Bunnag, D. AU - Vanijanond, S. AU - Charoenlarp, P. AU - Suntharasmai, P. AU - Chitamas, S. PY - 1987 DA - 1987// TI - Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose JO - Bull World Health Organ VL - 65 ID - Harinasuta1987 ER - TY - JOUR AU - Karbwang, J. AU - Bangchang, K. N. AU - Bunnag, D. AU - Harinasuta, T. PY - 1991 DA - 1991// TI - Pharmacokinetics and pharmacodynamics of mefloquine in Thai patients with acute falciparum malaria JO - Bull World Health Organ VL - 69 ID - Karbwang1991 ER - TY - STD TI - Bunnag D, Karbwang J, Viravan C, Chitamas S, Harinasuta T. Clinical trials of mefloquine with tetracycline. Southeast Asian J. trop. Med. Public Health 1992;23:377–382. ID - ref15 ER - TY - JOUR AU - Tshefu, A. K. AU - Gaye, O. AU - Kayentao, K. AU - Thompson, R. AU - Bhatt, K. M. AU - Sesay, S. S. S. PY - 2010 DA - 2010// TI - Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial JO - Lancet VL - 375 UR - https://doi.org/10.1016/S0140-6736(10)60322-4 DO - 10.1016/S0140-6736(10)60322-4 ID - Tshefu2010 ER - TY - JOUR AU - Karbwang, J. AU - Na Bangchang, K. AU - Bunnag, D. AU - Harinasuta, T. AU - Laothavorn, P. PY - 1993 DA - 1993// TI - Cardiac effect of halofantrine JO - Lancet VL - 342 UR - https://doi.org/10.1016/0140-6736(93)91631-U DO - 10.1016/0140-6736(93)91631-U ID - Karbwang1993 ER - TY - JOUR AU - Adjei, G. O. AU - Oduro-Boatey, C. AU - Rodrigues, O. P. AU - Hoegberg, L. C. AU - Alifrangis, M. AU - Kurtzhals, J. A. PY - 2012 DA - 2012// TI - Electrocardiographic study in Ghanaian children with uncomplicated malaria, treated with artesunate-amodiaquine or artemether-lumefantrine JO - Malar J VL - 11 UR - https://doi.org/10.1186/1475-2875-11-420 DO - 10.1186/1475-2875-11-420 ID - Adjei2012 ER - TY - JOUR AU - Ngouesse, B. AU - Basco, L. K. AU - Ringwald, P. AU - Keundjian, A. AU - Blackett, K. N. PY - 2001 DA - 2001// TI - Cardiac effects of amodiaquine and sulfadoxine-pyrimethamine in malaria-infected African patients JO - Am J Trop Med Hyg. VL - 65 UR - https://doi.org/10.4269/ajtmh.2001.65.711 DO - 10.4269/ajtmh.2001.65.711 ID - Ngouesse2001 ER - TY - JOUR AU - Lavallée, I. AU - Marc, E. AU - Moulin, F. AU - Treluyer, J. M. AU - Imbert, P. AU - Gendrel, D. PY - 2001 DA - 2001// TI - Cardiac rhythm disturbances and prolongation of the QTc interval with halofantrine JO - Arch Pédiatrie VL - 8 UR - https://doi.org/10.1016/S0929-693X(01)00537-1 DO - 10.1016/S0929-693X(01)00537-1 ID - Lavallée2001 ER - TY - JOUR AU - Sowunmi, A. AU - Falade, C. O. AU - Oduola, A. M. AU - Ogundahunsi, O. A. AU - Fehintola, F. A. AU - Gbotosho, G. O. PY - 1998 DA - 1998// TI - Cardiac effects of halofantrine in children suffering from acute uncomplicated falciparum malaria JO - Trans R Soc Trop Med Hyg VL - 92 UR - https://doi.org/10.1016/S0035-9203(98)91086-0 DO - 10.1016/S0035-9203(98)91086-0 ID - Sowunmi1998 ER - TY - JOUR AU - Miller, R. S. AU - Wongsrichanalai, C. AU - Buathong, N. AU - McDaniel, P. AU - Walsh, D. S. AU - Knirsch, C. PY - 2006 DA - 2006// TI - Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycin-quinine combinations: a randomized, dose-ranging study JO - Am J Trop Med Hyg. VL - 74 UR - https://doi.org/10.4269/ajtmh.2006.74.401 DO - 10.4269/ajtmh.2006.74.401 ID - Miller2006 ER - TY - JOUR AU - Sabchareon, A. AU - Chongsuphajaisiddhi, T. AU - Sinhasivanon, V. AU - Chanthavanich, P. AU - Attanath, P. PY - 1988 DA - 1988// TI - In vivo and in vitro responses to quinine and quinidine of Plasmodium falciparum JO - Bull World Health Organ VL - 66 ID - Sabchareon1988 ER - TY - JOUR AU - Liu, Y. AU - Hu, C. AU - Liu, G. AU - Jia, J. AU - Yu, C. AU - Zhu, J. PY - 2014 DA - 2014// TI - A replicate designed bioequivalence study to compare two fixed-dose combination products of artesunate and amodiaquine in healthy Chinese volunteers JO - Antimicrob Agents Chemother VL - 58 UR - https://doi.org/10.1128/AAC.02617-14 DO - 10.1128/AAC.02617-14 ID - Liu2014 ER - TY - JOUR AU - Karunajeewa, H. AU - Lim, C. AU - Hung, T. Y. AU - Ilett, K. F. AU - Denis, M. B. AU - Socheat, D. PY - 2003 DA - 2003// TI - Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria JO - Br J Clin Pharmacol VL - 57 UR - https://doi.org/10.1046/j.1365-2125.2003.01962.x DO - 10.1046/j.1365-2125.2003.01962.x ID - Karunajeewa2003 ER - TY - JOUR AU - Bethell, D. B. AU - Phuong, P. T. AU - Phuong, C. X. AU - Nosten, F. AU - Waller, D. AU - Davis, T. M. PY - 1996 DA - 1996// TI - Electrocardiographic monitoring in severe falciparum malaria JO - Trans R Soc Trop Med Hyg VL - 90 UR - https://doi.org/10.1016/S0035-9203(96)90241-2 DO - 10.1016/S0035-9203(96)90241-2 ID - Bethell1996 ER - TY - JOUR AU - Gargano, N. AU - Ubben, D. AU - Tommasini, S. AU - Bacchieri, A. AU - Corsi, M. AU - Bhattacharyya, P. C. PY - 2012 DA - 2012// TI - Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India JO - Malar J VL - 11 UR - https://doi.org/10.1186/1475-2875-11-233 DO - 10.1186/1475-2875-11-233 ID - Gargano2012 ER - TY - JOUR AU - Jittamala, P. AU - Pukrittayakamee, S. AU - Ashley, E. AU - Nosten, F. AU - Hanboonkunupakarn, B. AU - Lee, S. PY - 2015 DA - 2015// TI - Pharmacokinetic interactions between primaquine and pyronaridine-artesunate in healthy adult Thai subjects JO - Antimicrob Agents Chemother VL - 59 UR - https://doi.org/10.1128/AAC.03829-14 DO - 10.1128/AAC.03829-14 ID - Jittamala2015 ER - TY - JOUR AU - van Vugt, M. AU - Ezzet, F. AU - Nosten, F. AU - Gathmann, I. AU - Wilairatana, P. AU - Looareesuwan, S. PY - 1999 DA - 1999// TI - No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine JO - Am J Trop Med Hyg VL - 61 UR - https://doi.org/10.4269/ajtmh.1999.61.964 DO - 10.4269/ajtmh.1999.61.964 ID - van Vugt1999 ER - TY - JOUR AU - Manning, J. AU - Vanachayangkul, P. AU - Lon, C. AU - Spring, M. AU - So, M. AU - Sea, D. PY - 2014 DA - 2014// TI - Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval JO - Antimicrob Agents Chemother. VL - 58 UR - https://doi.org/10.1128/AAC.02667-14 DO - 10.1128/AAC.02667-14 ID - Manning2014 ER - TY - JOUR AU - Roggelin, L. AU - Pelletier, D. AU - Hill, J. N. AU - Feldt, T. AU - Hoffmann, S. AU - Ansong, D. PY - 2014 DA - 2014// TI - Disease-associated QT-shortage versus quinine associated QT-prolongation: Age dependent ECG-effects in Ghanaian children with severe malaria JO - Malar J VL - 13 UR - https://doi.org/10.1186/1475-2875-13-219 DO - 10.1186/1475-2875-13-219 ID - Roggelin2014 ER - TY - JOUR AU - Baiden, R. AU - Oduro, A. AU - Halidou, T. AU - Gyapong, M. AU - Sie, A. AU - Macete, E. PY - 2015 DA - 2015// TI - Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania JO - Malar J. VL - 14 UR - https://doi.org/10.1186/s12936-015-0664-9 DO - 10.1186/s12936-015-0664-9 ID - Baiden2015 ER - TY - JOUR AU - Bassat, Q. AU - Mulenga, M. AU - Tinto, H. AU - Piola, P. AU - Borrmann, S. AU - Menendez, C. PY - 2009 DA - 2009// TI - Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial JO - PLoS One VL - 4 UR - https://doi.org/10.1371/journal.pone.0007871 DO - 10.1371/journal.pone.0007871 ID - Bassat2009 ER - TY - JOUR AU - Valecha, N. AU - Phyo, A. P. AU - Mayxay, M. AU - Newton, P. M. AU - Krudsood, S. AU - Keomany, S. PY - 2010 DA - 2010// TI - An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia JO - PLoS One VL - 5 UR - https://doi.org/10.1371/journal.pone.0011880 DO - 10.1371/journal.pone.0011880 ID - Valecha2010 ER - TY - JOUR AU - Mayxay, M. AU - Keomany, S. AU - Khanthavong, M. AU - Souvannasing, P. AU - Stepniewska, K. AU - Khomthilath, T. PY - 2010 DA - 2010// TI - A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate- mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos JO - Am J Trop Med Hyg. VL - 83 UR - https://doi.org/10.4269/ajtmh.2010.10-0276 DO - 10.4269/ajtmh.2010.10-0276 ID - Mayxay2010 ER - TY - JOUR AU - Darpo, B. AU - Ferber, G. AU - Siegl, P. AU - Laurijssens, B. AU - Macintyre, F. AU - Toovey, S. PY - 2015 DA - 2015// TI - Evaluation of the QT effect of a combination of piperaquine and a novel anti-malarial drug candidate OZ439, for the treatment of uncomplicated malaria JO - Br J Clin Pharmacol VL - 80 UR - https://doi.org/10.1111/bcp.12680 DO - 10.1111/bcp.12680 ID - Darpo2015 ER - TY - JOUR AU - Krudsood, S. AU - Looareesuwan, S. AU - Wilairatama, P. AU - Leowattana, W. AU - Tangpukdee, N. AU - Chalermrut, K. PY - 2011 DA - 2011// TI - Effect of artesunate and mefloquine in combination on the Fridericia corrected QT intervals in Plasmodium falciparum infected adults from Thailand JO - Trop Med Int Heal VL - 16 UR - https://doi.org/10.1111/j.1365-3156.2010.02714.x DO - 10.1111/j.1365-3156.2010.02714.x ID - Krudsood2011 ER - TY - JOUR AU - Mytton, O. T. AU - Ashley, E. A. AU - Peto, L. AU - Price, R. N. AU - La, Y. AU - Hae, R. PY - 2007 DA - 2007// TI - Short report: electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria JO - Am J Trop Med Hyg. VL - 77 UR - https://doi.org/10.4269/ajtmh.2007.77.447 DO - 10.4269/ajtmh.2007.77.447 ID - Mytton2007 ER - TY - JOUR AU - Ogutu, B. AU - Juma, E. AU - Obonyo, C. AU - Jullien, V. AU - Carn, G. AU - Vaillant, M. PY - 2014 DA - 2014// TI - Fixed dose artesunate amodiaquine - a phase IIb, randomized comparative trial with non-fixed artesunate amodiaquine JO - Malar J. VL - 13 UR - https://doi.org/10.1186/1475-2875-13-498 DO - 10.1186/1475-2875-13-498 ID - Ogutu2014 ER - TY - JOUR AU - Wernicke, J. F. AU - Faries, D. AU - Breitung, R. AU - Girod, D. PY - 2005 DA - 2005// TI - QT correction methods in children and adolescents JO - J Cardiovasc Electrophysiol VL - 16 UR - https://doi.org/10.1046/j.1540-8167.2005.03520.x DO - 10.1046/j.1540-8167.2005.03520.x ID - Wernicke2005 ER - TY - JOUR AU - Price, R. N. AU - Nosten, F. AU - White, N. J. PY - 1998 DA - 1998// TI - Letters to the editor JO - Am J Trop Med Hyg VL - 59 UR - https://doi.org/10.4269/ajtmh.1998.59.504 DO - 10.4269/ajtmh.1998.59.504 ID - Price1998 ER - TY - STD TI - World Health Organisation. Definitions by WHO. 2003. http://www.who.int/medicines/areas/quality_safety/safety_efficacy/trainingcourses/definitions.pdf. Accessed 18 Oct 2018. UR - http://www.who.int/medicines/areas/quality_safety/safety_efficacy/trainingcourses/definitions.pdf ID - ref42 ER - TY - STD TI - Evidence synthesis and meta-analysis: report of CIOMS Working Group X. Council for International Organizations of Medical (CIOMS). 2016. ID - ref43 ER - TY - STD TI - WHO Evidence Review Group. The cardiotoxicity of antimalarials. 2017. http://www.who.int/malaria/mpac/mpac-mar2017-erg-cardiotoxicity-report-session2.pdf. Accessed 18 Oct 2018. UR - http://www.who.int/malaria/mpac/mpac-mar2017-erg-cardiotoxicity-report-session2.pdf ID - ref44 ER - TY - JOUR AU - Chan, X. H. S. AU - Win, Y. N. AU - Mawer, L. J. AU - Tan, J. Y. AU - Brugada, J. AU - White, N. J. PY - 2018 DA - 2018// TI - Risk of sudden unexplained death after use of dihydroartemisinin – piperaquine for malaria: a systematic review and Bayesian meta-analysis JO - Lancet Infect Dis World Health Organization VL - 3099 ID - Chan2018 ER - TY - JOUR AU - Sagara, I. AU - Beavogui, A. H. AU - Zongo, I. AU - Soulama, I. AU - Borghini-Fuhrer, I. AU - Fofana, B. PY - 2018 DA - 2018// TI - Pyronaridine–artesunate or dihydroartemisinin–piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial JO - Lancet VL - 391 UR - https://doi.org/10.1016/S0140-6736(18)30291-5 DO - 10.1016/S0140-6736(18)30291-5 ID - Sagara2018 ER - TY - JOUR AU - Rueangweerayut, R. o. n. n. a. t. r. a. i. AU - Phyo, A. u. n. g. P. y. a. e. AU - Uthaisin, C. h. i. r. a. p. o. n. g. AU - Poravuth, Y. i. AU - Binh, T. r. a. n. Q. u. a. n. g. AU - Tinto, H. a. l. i. d. o. u. AU - Pénali, L. o. u. i. s. K. AU - Valecha, N. e. e. n. a. AU - Tien, N. o. n. g. T. h. i. AU - Abdulla, S. a. l. i. m. AU - Borghini-Fuhrer, I. s. a. b. e. l. l. e. AU - Duparc, S. t. e. p. h. a. n. AU - Shin, C. h. a. n. g. -. S. i. k. AU - Fleckenstein, L. a. w. r. e. n. c. e. PY - 2012 DA - 2012// TI - Pyronaridine–Artesunate versus Mefloquine plus Artesunate for Malaria JO - New England Journal of Medicine VL - 366 UR - https://doi.org/10.1056/NEJMoa1007125 DO - 10.1056/NEJMoa1007125 ID - Rueangweerayut2012 ER - TY - JOUR AU - Morris, C. A. AU - Lopez-Lazaro, L. AU - Jung, D. AU - Methaneethorn, J. AU - Duparc, S. AU - Borghini-Fuhrer, I. PY - 2012 DA - 2012// TI - Drug-drug interaction analysis of pyronaridine/artesunate and ritonavir in healthy volunteers JO - Am J Trop Med Hyg United States VL - 86 UR - https://doi.org/10.4269/ajtmh.2012.11-0558 DO - 10.4269/ajtmh.2012.11-0558 ID - Morris2012 ER - TY - JOUR AU - Kayentao, K. AU - Doumbnao, O. M. AU - Kimani, J. AU - Tshefu, A. K. AU - Kokolomami, J. H. T. AU - Ramharter, M. PY - 2012 DA - 2012// TI - Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomigobara K Pénali, Louis K Offianan, André T Bhatt, Kirazed controlled trial JO - Malar J VL - 11 UR - https://doi.org/10.1186/1475-2875-11-364 DO - 10.1186/1475-2875-11-364 ID - Kayentao2012 ER - TY - JOUR AU - Viskin, S. AU - Rosovski, U. AU - Sands, A. J. AU - Chen, E. AU - Kistler, P. M. AU - Kalman, J. M. PY - 2005 DA - 2005// TI - Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one. Hear JO - Rhythm VL - 2 UR - https://doi.org/10.1016/j.hrthm.2005.02.011 DO - 10.1016/j.hrthm.2005.02.011 ID - Viskin2005 ER - TY - JOUR AU - Isbister, G. K. PY - 2015 DA - 2015// TI - How do we assess whether the QT interval is abnormal: myths, formulae and fixed opinion JO - Clin Toxicol VL - 53 UR - https://doi.org/10.3109/15563650.2015.1014044 DO - 10.3109/15563650.2015.1014044 ID - Isbister2015 ER - TY - JOUR AU - Malik, M. AU - Färbom, P. AU - Batchvarov, V. AU - Hnatkova, K. AU - Camm, A. J. PY - 2002 DA - 2002// TI - Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval JO - Heart VL - 87 UR - https://doi.org/10.1136/heart.87.3.220 DO - 10.1136/heart.87.3.220 ID - Malik2002 ER - TY - STD TI - International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). ICH Topic E 14 The Clinical Evaluation of QT / QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs (CHMP/ICH/2/04). 2005. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002879.pdf. Accessed 18 Oct 2018. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002879.pdf ID - ref53 ER -